Cun Long, Ronghua Zhou, Bin Lin, Jin Liu, Shuyi Lrou
Department of Cardiopulmonary Bypass Laboratory, Cardiovascular Institute & Fu Wai Hospital, CAMS and PUMC, 100037 Beijing, China.
ASAIO J. 2007 Nov-Dec;53(6):762-5. doi: 10.1097/MAT.0b013e31815766e3.
Inhibition of Na/H exchanger isoform-1 (NHE1) has shown significant protection in adult myocardium during ischemia/reperfusion injury; however, the effect is unclear in immature myocardium. We evaluated the effects of HOE642 (a potent, highly selective NHE1 inhibitor) preconditioning on immature rabbit hearts. Twenty immature (2-3 weeks old) New Zealand white rabbits were randomly divided into the control group (n = 10) and the HOE642 preconditioning group (n = 10). The immature isolated hearts were subjected to 45 minutes of normothermic global ischemia plus 60 minutes of reperfusion after being established on the Langendorff apparatus. During reperfusion, the recovery rates of cardiac function (LVDP, +dp/dtmax, -dp/dtmax, and coronary flow) were about 90% in the HOE642 treated group and about 50% in the control group (p < 0.05). HOE642 preconditioning can significantly decrease the release of cardiac specific enzymes CK, CK-MB and LDH (p < 0.05) and the myocardial water content (p < 0.05). Meanwhile, HOE642 markedly attenuated intracellular calcium overload (265.8 +/- 41.1 vs. 500.7 +/- 60.8 mg/kg dry wt) (p < 0.01). The blinded ultrastructural assessment under transmission electron microscopy illustrated that preconditioning with HOE642 produced evident myocyte salvage. This study demonstrates that preconditioning with HOE642 provides a significant protection during ischemia/reperfusion injury in immature myocardium, mostly by reducing myocardial calcium overload.
抑制钠/氢交换体1型(NHE1)已显示出在成年心肌缺血/再灌注损伤期间具有显著的保护作用;然而,其在未成熟心肌中的作用尚不清楚。我们评估了HOE642(一种强效、高选择性NHE1抑制剂)预处理对未成熟兔心脏的影响。将20只未成熟(2 - 3周龄)的新西兰白兔随机分为对照组(n = 10)和HOE642预处理组(n = 10)。未成熟离体心脏在Langendorff装置上建立后,经历45分钟的常温全心缺血加60分钟的再灌注。在再灌注期间,HOE642处理组的心功能恢复率(左心室舒张压、+dp/dtmax、-dp/dtmax和冠脉流量)约为90%,而对照组约为50%(p < 0.05)。HOE642预处理可显著降低心肌特异性酶CK、CK-MB和LDH的释放(p < 0.05)以及心肌含水量(p < 0.05)。同时,HOE642显著减轻细胞内钙超载(265.8±41.1对500.7±60.8mg/kg干重)(p < 0.01)。透射电子显微镜下的盲法超微结构评估表明,HOE642预处理可产生明显的心肌细胞挽救作用。本研究表明,HOE642预处理在未成熟心肌缺血/再灌注损伤期间提供显著保护,主要是通过减少心肌钙超载实现的。